From the 2018 midterm election results to the rise of CBD, Michael McGuffin, president of the American Herbal Products Association, talks about how the association is approaching the most recent changes in the supplements space.

Getting your regulatory affairs department or a consultant involved early in the development process can save multiple headaches later when bringing new products to market. The global regulatory goalposts are moving all the time, and R&D teams need...

It’s a global industry and there’s a lot happening. We know it’s not always easy keeping up with everything that’s happening around the world that could impact the US dietary supplements industry. The answer? Our weekly round-up of key news from across...

Increased consumer awareness around probiotics – linked to an ever growing body of benefits – is opening up new markets around the world, with China booming and new opportunities in Latin America, says George Paraskevakos, executive director of the International...

The Natural Products Association’s stance on CBD is to take FDA’s word on the controversial ingredient, until someone takes the front door with the Agency and files an NDI or a GRAS notification with the FDA for CBD.

Despite the equivocal reports in the mainstream media of the recently released omega-3s trials, the huge statistical power of the studies means the promising secondary endpoints can be trusted, experts say.